Hyundai Pharmaceutical Co., Ltd. (KRX: 004310)

Hyundai Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is December - November.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Nov 30, 2013	Nov 30, 2013	Nov 30, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009
Cash & Equivalents	14,087	14,087	16,267	13,629	11,320	7,531
Short-Term Investments	543.24	543.24	343.24	343.24	-	120
Cash & Short-Term Investments	14,630	14,630	16,610	13,972	11,320	7,651
Cash Growth	-11.92%	-11.92%	18.88%	23.43%	47.95%	-41.97%
Accounts Receivable	42,522	42,522	43,050	53,981	50,842	53,108
Other Receivables	2,239	2,239	2,271	1,987	1,563	1,970
Receivables	44,762	44,762	45,320	55,969	52,405	55,078
Inventory	20,971	20,971	24,100	17,058	14,026	16,015
Prepaid Expenses	71.55	71.55	105.6	152.9	111.24	76.64
Other Current Assets	42.24	42.24	38.25	357.93	74.29	208.4
Total Current Assets	80,477	80,477	86,174	87,510	78,314	79,082
Property, Plant & Equipment	33,346	33,346	33,097	40,726	43,167	46,320
Long-Term Investments	5,832	5,832	5,474	3,797	7,320	6,948
Other Intangible Assets	1,829	1,829	2,411	2,448	378.93	502.39
Other Long-Term Assets	21,919	21,919	22,746	22,467	1,803	1,414
Total Assets	143,403	143,403	149,903	156,948	130,982	134,268
Accounts Payable	6,855	6,855	5,561	5,077	3,162	5,133
Accrued Expenses	407.52	407.52	554.44	561.66	35.98	61.89
Short-Term Debt	20,750	20,750	29,286	27,819	22,000	23,522
Current Income Taxes Payable	58.94	58.94	315.93	1,113	678.22	54.94
Current Unearned Revenue	-	-	-	6.75	-	-
Other Current Liabilities	8,572	8,572	8,102	10,480	9,597	9,413
Total Current Liabilities	36,644	36,644	43,820	45,057	35,473	38,185
Long-Term Deferred Tax Liabilities	1,932	1,932	2,126	3,597	882.5	588.19
Other Long-Term Liabilities	234.02	234.02	75.6	0.32	-	-
Total Liabilities	42,191	42,191	50,216	52,632	38,477	41,670
Common Stock	14,000	14,000	14,000	14,000	14,000	14,000
Additional Paid-In Capital	6,569	6,569	6,569	6,569	6,386	6,386
Retained Earnings	75,362	75,362	74,236	80,230	68,406	66,662
Treasury Stock	-13,532	-13,532	-13,532	-13,532	-13,532	-11,474
Comprehensive Income & Other	18,307	18,307	17,953	16,590	17,245	17,024
Total Common Equity	100,705	100,705	99,225	103,857	92,505	92,598
Minority Interest	506.57	506.57	461.84	459.68	-	-
Shareholders' Equity	101,212	101,212	99,687	104,316	92,505	92,598
Total Liabilities & Equity	143,403	143,403	149,903	156,948	130,982	134,268
Total Debt	20,750	20,750	29,286	27,819	22,000	23,522
Net Cash (Debt)	-6,120	-6,120	-12,676	-13,847	-10,680	-15,871
Net Cash Per Share	-260.97	-260.97	-541.03	-585.72	-447.41	-645.31
Filing Date Shares Outstanding	23.45	23.45	23.45	23.45	23.45	24.48
Total Common Shares Outstanding	23.45	23.45	23.45	23.45	23.45	24.48
Working Capital	43,833	43,833	42,354	42,453	42,840	40,898
Book Value Per Share	4294.60	4294.60	4231.46	4428.99	3944.89	3782.43
Tangible Book Value	98,877	98,877	96,814	101,409	92,126	92,096
Tangible Book Value Per Share	4216.61	4216.61	4128.64	4324.59	3928.73	3761.91
Land	18,743	18,743	17,818	24,546	22,567	25,917
Buildings	19,464	19,464	19,365	19,388	18,629	20,272
Machinery	17,480	17,480	16,418	16,311	15,901	15,059
Construction In Progress	701.51	701.51	779.93	206.76	6,520	4,350

Source: S&P Capital IQ. Standard template. Financial Sources.